Jaguar Health, Inc.: Jaguar Health Subsidiary Receiving Preclinical Services from the National Institute of Allergy and Infectious Diseases for New Preclinical Study Initiated January 6, 2021 for Lechlemer Plant-Based Drug Candidate for the Symptomatic Re
SAN FRANCISCO,
CA / ACCESSWIRE / January 6, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ( Jaguar or the Company ) announced today that the 28-day preclinical toxicology and safety study in dogs began today, January 6, 2021, to support development of lechlemer, the second generation, plant-based anti-secretory drug candidate of Napo Pharmaceuticals ( Napo ), Jaguar s wholly owned subsidiary, for the symptomatic relief of diarrhea from cholera.
As previously announced, Napo is receiving preclinical services from the National Institute of Allergy and Infectious Diseases ( NIAID ) to support lechlemer development. Under NIAID s suite of preclinical services, NIAID-funded contractors are conducting the 28-day dog study. NIAID is part o
Share this article
Share this article
CARLSBAD, Calif., Jan. 6, 2021 /PRNewswire/ SOLVD Health (www.solvdhealth.com), a privately held company focused on preventing disease by making actionable and contextual health information accessible to everyone, is preparing to launch a U.S. clinical study of its non-invasive colorectal cancer (CRC) screening test, LifeKit® Prevent. The test is being developed in partnership with Metabiomics, a subsidiary of SOLVD Health. The PREVENT study protocol is now available on the U.S. National Library of Medicine s ClinicalTrials.gov database, which includes privately and publicly funded clinical studies conducted around the world.
LifeKit Prevent is a qualitative in vitro diagnostic test that is designed to detect and analyze microbial genomics biomarkers in human stool samples that are strongly associated with specific stages of CRC progression. The test is intended to aid in the detection of precancerous and cancerous lesions (colorectal n
The U.S. Department of Health & Human Services has persuaded the FDA to waive the hefty surprise fees for local distilleries that made hand sanitizer for their communities.
Central Nebraska agencies CARES Act funding ends today | State and Regional News kearneyhub.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kearneyhub.com Daily Mail and Mail on Sunday newspapers.
Just before 2020 was concluded, Congress passed H.R. 133, the Consolidated Appropriations Act, to provide coronavirus relief and federal appropriations until Sept. 20, 2021. The package includes a number of priorities championed by Oklahoma Congressman Frank Lucas, aimed at benefiting individuals, families, business and agriculture.
One such program was introduced in July 2020 by Lucas and Minnesota Congressman Collin Peterson. The RAMP-UP Act, which established a grant program to help small meat producers make the necessary improvements to meet federal food safety standards and satisfy the meat production disruptions caused by the COVID-19 pandemic.
According to Lucasâ office, the Consolidated Appropriations Act includes an amended version of the RAMP-UP Act, establishing a $60 million grant program for small meat and poultry processors to upgrade operations in order to move to federal inspection or state inspection programs that allow for the sale of products across state li